Interestingly, the correlation between IL-9 and IL-15 was already reported in patients with RR-MS, and this association was related to the increased levels of both cytokines in patients receiving prednisolone treatment than those without immunotherapy during the relapse (22). The gene discussed is IL9; the disease is myeloid sarcoma.